211 related articles for article (PubMed ID: 16491293)
21. Role of ATF7-TAF12 interactions in the vitamin D response hypersensitivity of osteoclast precursors in Paget's disease.
Teramachi J; Hiruma Y; Ishizuka S; Ishizuka H; Brown JP; Michou L; Cao H; Galson DL; Subler MA; Zhou H; Dempster DW; Windle JJ; Roodman GD; Kurihara N
J Bone Miner Res; 2013 Jun; 28(6):1489-500. PubMed ID: 23426901
[TBL] [Abstract][Full Text] [Related]
22. Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.
Menaa C; Reddy SV; Kurihara N; Maeda H; Anderson D; Cundy T; Cornish J; Singer FR; Bruder JM; Roodman GD
J Clin Invest; 2000 Jun; 105(12):1833-8. PubMed ID: 10862799
[TBL] [Abstract][Full Text] [Related]
23. Insights into the pathogenesis of Paget's disease.
Roodman GD
Ann N Y Acad Sci; 2010 Mar; 1192():176-80. PubMed ID: 20392234
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in Paget's disease.
Hoyland JA; Freemont AJ; Sharpe PT
J Bone Miner Res; 1994 Jan; 9(1):75-80. PubMed ID: 8154312
[TBL] [Abstract][Full Text] [Related]
25. Pagetic osteoclasts formed in vitro: absence of paracrystalline inclusions.
Roodman GD; Ohsaki Y; Miller MM; Demulder A; Hosking D; Singer FR; McManus LM
J Submicrosc Cytol Pathol; 1998 Apr; 30(2):315-27. PubMed ID: 9648296
[TBL] [Abstract][Full Text] [Related]
26. Multinucleated cells formed in vitro from Paget's bone marrow express viral antigens.
Mills BG; Frausto A; Singer FR; Ohsaki Y; Demulder A; Roodman GD
Bone; 1994; 15(4):443-8. PubMed ID: 7917585
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D3 from pagetic bone marrow cells.
Ishizuka S; Kurihara N; Miura D; Takenouchi K; Cornish J; Cundy T; Reddy SV; Roodman GD
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):331-4. PubMed ID: 15225795
[TBL] [Abstract][Full Text] [Related]
28. Measles virus nucleocapsid protein modulates the Signal Regulatory Protein-β1 (SIRPβ1) to enhance osteoclast differentiation in Paget's disease of bone.
Sundaram K; Sambandam Y; Shanmugarajan S; Rao DS; Reddy SV
Bone Rep; 2017 Dec; 7():26-32. PubMed ID: 28840181
[TBL] [Abstract][Full Text] [Related]
29. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA
J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498
[TBL] [Abstract][Full Text] [Related]
30. [Contribution of modern research technics to the identification of a virus in Paget's disease of bone].
Rebel A; Basle MF; Fournier JG; Russel WC
Bull Assoc Anat (Nancy); 1986 Jun; 70(209):15-20. PubMed ID: 3620721
[TBL] [Abstract][Full Text] [Related]
31. Failure to detect measles virus ribonucleic acid in bone cells from patients with Paget's disease.
Matthews BG; Afzal MA; Minor PD; Bava U; Callon KE; Pitto RP; Cundy T; Cornish J; Reid IR; Naot D
J Clin Endocrinol Metab; 2008 Apr; 93(4):1398-401. PubMed ID: 18230662
[TBL] [Abstract][Full Text] [Related]
32. Eosinophil chemotactic factor-L (ECF-L): a novel osteoclast stimulating factor.
Oba Y; Chung HY; Choi SJ; Roodman GD
J Bone Miner Res; 2003 Jul; 18(7):1332-41. PubMed ID: 12854845
[TBL] [Abstract][Full Text] [Related]
33. 1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease.
Menaa C; Barsony J; Reddy SV; Cornish J; Cundy T; Roodman GD
J Bone Miner Res; 2000 Feb; 15(2):228-36. PubMed ID: 10703924
[TBL] [Abstract][Full Text] [Related]
34. SOCS-1/3 participation in FGF-2 signaling to modulate RANK ligand expression in paget's disease of bone.
Sundaram K; Senn J; Reddy SV
J Cell Biochem; 2013 Sep; 114(9):2032-8. PubMed ID: 23553658
[TBL] [Abstract][Full Text] [Related]
35. Pathobiology of Paget's Disease of Bone.
Galson DL; Roodman GD
J Bone Metab; 2014 May; 21(2):85-98. PubMed ID: 25025000
[TBL] [Abstract][Full Text] [Related]
36. Absence of paramyxovirus RNA in cultures of pagetic bone cells and in pagetic bone.
Birch MA; Taylor W; Fraser WD; Ralston SH; Hart CA; Gallagher JA
J Bone Miner Res; 1994 Jan; 9(1):11-6. PubMed ID: 8154304
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of c-fos protooncogene expression in pagetic osteoclasts.
Hoyland J; Sharpe PT
J Bone Miner Res; 1994 Aug; 9(8):1191-4. PubMed ID: 7976501
[TBL] [Abstract][Full Text] [Related]
38. The role of immune cells and inflammatory cytokines in Paget's disease and multiple myeloma.
Ehrlich LA; Roodman GD
Immunol Rev; 2005 Dec; 208():252-66. PubMed ID: 16313353
[TBL] [Abstract][Full Text] [Related]
39. Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.
Roodman GD; Kurihara N; Ohsaki Y; Kukita A; Hosking D; Demulder A; Smith JF; Singer FR
J Clin Invest; 1992 Jan; 89(1):46-52. PubMed ID: 1729280
[TBL] [Abstract][Full Text] [Related]
40. Immortalization of osteoclast precursors by targeting Bcl -XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice.
Hentunen TA; Reddy SV; Boyce BF; Devlin R; Park HR; Chung H; Selander KS; Dallas M; Kurihara N; Galson DL; Goldring SR; Koop BA; Windle JJ; Roodman GD
J Clin Invest; 1998 Jul; 102(1):88-97. PubMed ID: 9649561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
